Korea Continuous Glucose Monitoring Devices Market Market Dynamics and Growth Analysis

Key Insights

The Korea Continuous Glucose Monitoring (CGM) Devices market is experiencing robust growth, projected to reach \$84.24 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 9.40% from 2025 to 2033. This expansion is driven by several factors. Rising prevalence of diabetes in South Korea, coupled with increasing awareness about the benefits of CGM technology for improved diabetes management, fuels market demand. Technological advancements leading to smaller, more user-friendly devices with enhanced accuracy and longer battery life are also key drivers. Furthermore, supportive government initiatives aimed at improving healthcare accessibility and affordability contribute to market growth. The market segmentation reveals significant regional variations, with metropolitan areas like Seoul, Busan, and Incheon exhibiting higher adoption rates compared to other provinces. In terms of components, the market is primarily driven by demand for advanced sensors, followed by durable components such as receivers and transmitters. Leading players like Dexcom, Eversense, Medtronic, Abbott, and Ascensia are actively competing to capture market share through product innovation and strategic partnerships. The competitive landscape is marked by ongoing technological advancements, focusing on improved data analytics integration and seamless connectivity with other diabetes management tools.

The forecast period from 2025 to 2033 anticipates sustained market growth fueled by an aging population, further increasing the prevalence of diabetes and associated complications. Increased physician recommendations and improved patient understanding of the clinical and lifestyle benefits of CGM technology will contribute significantly to market expansion. However, factors like high device costs and potential reimbursement challenges could act as restraints, although the overall positive market outlook remains strong. The market's evolution will likely be shaped by future innovations such as non-invasive CGM technologies and improved data integration capabilities within broader digital health platforms. The presence of established multinational companies alongside potential emerging local players suggests a dynamic and competitive market with significant growth potential over the long term.

Korea Continuous Glucose Monitoring Devices Market Report: 2019-2033

This comprehensive report provides a detailed analysis of the dynamic Korea Continuous Glucose Monitoring (CGM) Devices market, offering invaluable insights for industry stakeholders, investors, and researchers. Covering the period from 2019 to 2033, with a focus on 2025, this report meticulously examines market size, growth trends, competitive dynamics, and future outlook. The report leverages extensive data analysis and incorporates key industry developments to paint a clear picture of this rapidly evolving market.

Korea Continuous Glucose Monitoring Devices Market Structure & Competitive Landscape

The Korean CGM devices market exhibits a moderately concentrated structure, with key players like Dexcom Inc, Eversense, Medtronic PLC, Abbott Diabetes Care Inc, and Ascensia vying for market share. The market concentration ratio (CR4) is estimated at xx% in 2025, indicating a competitive yet consolidated landscape. Innovation is a crucial driver, with companies continuously developing more accurate, user-friendly, and integrated CGM systems. Regulatory approvals and reimbursement policies significantly influence market access and adoption. Substitute products, primarily self-monitoring blood glucose (SMBG) devices, continue to pose competitive pressure, although CGM's superior real-time monitoring capabilities are driving market shift. The end-user segment comprises primarily diabetic patients, categorized by type 1 and type 2 diabetes, and their varying needs influence device preference. Mergers and acquisitions (M&A) activity is significant, as evidenced by recent deals such as Medtronic PLC's acquisition of EOFlow Co. Ltd. The number of M&A deals in the Korean CGM market from 2019-2024 was xx, with a total value of xx Million USD. This trend indicates consolidation and a drive toward broader market reach and technological advancement.

Korea Continuous Glucose Monitoring Devices Market Trends & Opportunities

The Korean CGM devices market is experiencing robust growth, with an estimated market size of xx Million USD in 2025 and a projected Compound Annual Growth Rate (CAGR) of xx% from 2025 to 2033. This growth is fuelled by rising diabetes prevalence, increasing awareness of CGM benefits (improved glycemic control and reduced complications), and technological advancements leading to smaller, more accurate, and user-friendly devices. Consumer preferences are shifting toward integrated systems offering seamless data management and integration with insulin pumps. The market penetration rate of CGM devices in Korea is currently estimated at xx%, signifying substantial untapped potential for future growth. The competitive landscape is marked by fierce rivalry among established players and emerging companies offering innovative technologies. Continuous innovation, particularly in areas like non-invasive glucose monitoring and improved data analytics, presents significant opportunities for market expansion and revenue generation. This involves advanced algorithm development, improved sensor technology, enhanced data connectivity and user interface design.

Dominant Markets & Segments in Korea Continuous Glucose Monitoring Devices Market

Based on the provincial distribution, Seoul holds the largest market share in the Korean CGM devices market in 2025, accounting for xx% of the total market value, driven by higher healthcare expenditure, better access to advanced technology, and a denser population with a high prevalence of diabetes. Busan and Daegu Metropolitan City follow, respectively capturing xx% and xx% of the market. Incheon Metropolitan City and Gwangju show relatively lower market shares, due to factors such as lower healthcare expenditure and diabetes prevalence, with xx% and xx% respectively. The "Other Provinces" segment constitutes the remaining xx% of the market.

• Key Growth Drivers in Seoul: High concentration of healthcare facilities, higher disposable income, increased awareness among patients and healthcare professionals.
• Key Growth Drivers in Other Provinces: Expanding access to advanced medical technologies, government initiatives promoting preventative healthcare.

Regarding the component segment, sensors dominate the market, representing xx% of the total market value in 2025. This is primarily due to the consumables nature of sensors requiring frequent replacement. Durables (receivers and transmitters) comprise the remaining xx% of the market.

Korea Continuous Glucose Monitoring Devices Market Product Analysis

The Korean CGM devices market displays a range of products varying in features, accuracy, and integration capabilities. Continuous innovation focuses on enhancing sensor accuracy, reducing sensor insertion pain, extending sensor lifespan, developing smaller, more discreet devices, and improving data integration with other diabetes management technologies. This market is driven by a strong demand for ease of use and data connectivity, pushing manufacturers to develop user-friendly interfaces and seamless data integration with smartphones and other healthcare devices. The market fit of these products hinges on accurate glucose measurement, reliability, affordability, and user experience.

Key Drivers, Barriers & Challenges in Korea Continuous Glucose Monitoring Devices Market

Key Drivers: Rising prevalence of diabetes in Korea is a primary driver, fueled by lifestyle changes and an aging population. Technological advancements in sensor technology, data analytics, and integration capabilities are also propelling market growth. Favorable government policies and reimbursement schemes further incentivize adoption.

Key Barriers & Challenges: High device costs and limited insurance coverage create significant barriers to adoption. Supply chain disruptions, particularly concerning the availability of key components, can impact production and market supply. Furthermore, intense competition among established and emerging players creates pricing pressures. The impact of these factors is estimated to limit market expansion by approximately xx% in the forecast period.

Growth Drivers in the Korea Continuous Glucose Monitoring Devices Market Market

Technological advancements driving miniaturization, improved accuracy, and seamless data integration are key growth drivers. Increasing awareness of CGM's benefits among both patients and healthcare professionals is also significant. Supportive government policies and insurance coverage expansion greatly influence market adoption and growth.

Challenges Impacting Korea Continuous Glucose Monitoring Devices Market Growth

High device costs remain a considerable barrier, limiting access for many patients. Regulatory hurdles and complex approval processes can slow down product launches. Intense competition among major players necessitates continuous innovation and cost optimization to maintain market share.

Key Players Shaping the Korea Continuous Glucose Monitoring Devices Market Market

• Dexcom Inc
• Eversense
• Medtronic PLC (Medtronic PLC)
• Abbott Diabetes Care Inc (Abbott)
• Ascensia

Significant Korea Continuous Glucose Monitoring Devices Market Industry Milestones

• May 2023: Medtronic PLC's acquisition of EOFlow Co. Ltd. expands Medtronic's product portfolio and strengthens its position in the Korean CGM market. This acquisition is expected to significantly impact market share and competition.
• Jan 2023: A 10% price increase of Abbott Freestyle Libre in Korea due to inflation impacts affordability and access, potentially slowing down market growth.

Future Outlook for Korea Continuous Glucose Monitoring Devices Market Market

The Korean CGM devices market is poised for continued expansion, driven by ongoing technological innovation, rising diabetes prevalence, and supportive government initiatives. Strategic partnerships, targeted marketing campaigns, and the development of more affordable and accessible devices are crucial for maximizing market potential. The focus on improving patient outcomes through advanced data analytics and integration with other diabetes management technologies will also shape future growth.

Korea Continuous Glucose Monitoring Devices Market Segmentation

• 1. Component
  • 1.1. Sensors
  • 1.2. Durables (Receivers and Transmitters)
• 2. Provinces (Quantitative Analysis)
  • 2.1. Seoul
  • 2.2. Busan
  • 2.3. Daegu Metropolitan City
  • 2.4. Incheon Metropolitan City
  • 2.5. Gwangju
  • 2.6. Other Provinces

Korea Continuous Glucose Monitoring Devices Market Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific